Antihistamines in Pregnancy

1Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Allergic disorders are increasing prevalence from decades. Often of allergic diseases such as chronic urticaria in some aspects of quality of life of patients affected. Outdoor and indoor allergens can cause aggravation of symptoms in allergic patients. H1-antihistamines have been available for decades and those are over-the-counter drugs. The first generation H1-antihistamines have anticholinergic and sedative effects. Basically, their use (H1 blockers) for the routine management of allergic diseases is not recommended. Second generation H1-antihistamines (bilastine, cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, and rupatadine) have minimally or non-sedating and free of anticholinergic effects. About 10–15% of pregnant women used antihistamine within pregnancy.

Author supplied keywords

Cite

CITATION STYLE

APA

Ghaffari, J. (2023). Antihistamines in Pregnancy. Journal of Pediatrics Review. Negah Institute for Scientific Communication. https://doi.org/10.32598/jpr.11.4.28.19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free